Drawing for BINSPECIFIC

USPTO serial 87473882

BINSPECIFIC

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
Examiner
ALTREE, NICHOLAS
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with BINSPECIFIC?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
001Biochemicals, namely, bi-specific antibodies with one arm conferring cell type specificity; diagnostic and therapeutic kits consisting of bi-specific antibodies with one arm conferring cell type specificity; bi-specific antibodies with one arm conferring cell type specificity for laboratory and research useACTIVE
005Therapeutic and diagnostic agents and preparations consisting primarily of biochemicals for use in cancer therapies; engineered cell therapies for medical purposes, namely, for use in treating cancer; therapeutic and diagnostic agents, preparations and substances for medical purposes; immunotherapies and therapeutic and diagnostic agents, preparations and substances for medical purposes; immunotherapies and therapeutic and diagnostic agents, preparations and substances in the field of oncology for medical purposesACTIVE
042Scientific research and development in the field of therapeutic biochemicals, engineered cell therapies and immunotherapy; medical and scientific research and development for agents, preparations, products and technology in the immunotherapy and oncology; providing medical and scientific research information in the fields of biochemicals, engineered cell therapies, immunotherapy, and oncology; scientific investigations for medical purposes; medical research in the fields of biochemicals, engineered cell therapies, immunotherapy, and oncologyACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jan 25, 2021MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jan 25, 2021ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 19, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 18, 2020EX5GSOU EXTENSION 5 GRANTED
Jun 17, 2020EXT5SOU EXTENSION 5 FILED
Jun 17, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 14, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 12, 2019EX4GSOU EXTENSION 4 GRANTED
Dec 12, 2019EXT4SOU EXTENSION 4 FILED
Dec 12, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 12, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 10, 2019EX3GSOU EXTENSION 3 GRANTED
Jun 10, 2019EXT3SOU EXTENSION 3 FILED
Jun 10, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 13, 2019ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Feb 9, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 8, 2019EX2GSOU EXTENSION 2 GRANTED
Jan 2, 2019AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL
Dec 17, 2018EXT2SOU EXTENSION 2 FILED
Dec 17, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 16, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 14, 2018EX1GSOU EXTENSION 1 GRANTED
Jun 14, 2018EXT1SOU EXTENSION 1 FILED
Jun 14, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 19, 2017NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 24, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 24, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 4, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 12, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Aug 31, 2017DOCKASSIGNED TO EXAMINER
Jun 9, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 6, 2017NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance